Some of the best-performing biopharma stocks in recent years belong to companies developing cancer drugs, and it looks as if this trend is going to continue throughout 2017 and into the foreseeable future. Estimated global spending for oncology medicines is expected to grow from $107 billion in 2015 to $150 billion by 2020 as life spans lengthen across the developed world.There are hundreds of biotech start-ups attempting to develop the next breakthrough therapy, but investors can avoid a great deal of risk by focusing on companies with winning track records and clear paths to continued growth.
Comment on 3 Top Cancer Drug Stocks to Buy in 2017
newsfeedback@fool.com (Cory Renauer), The Motley Fool
Mon, 03/27/2017 - 1:29pm
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more